An observational study in Hypophosphatemia, sponsored by University of Zurich. Active, not recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-01.
Sponsored by University of Zurich · Observational
The aim of this study is to generate evidence regarding hypophosphatemia after iron infusion in lung transplant recipients in context of anemia and/or iron deficiency.
53 studies on the registry are indexed under Hypophosphatemia; 16 are open to participants now.
This study's planned enrollment of 250 is above the median of 105 across 26 observational studies indexed under Hypophosphatemia.
Browse Hypophosphatemia studies →University of Zurich is the lead sponsor of 1,049 studies on the registry; 133 are open to participants now.
Counted across the registry records on this site, refreshed daily.
lung transplant recipient
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
no intervention
Change of serum phosphate level
Change of serum phosphate level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of urin phosphate level
Change of urin phosphate level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of hemoglobin
Change of hemoglobin level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of mean corpuscular volume (MCV)
Changes of serum MCV level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of mean corpuscular hemoglobin (MCH)
Change of serum MCH level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of serum magnesium
Change of serum magnesium level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of serum and urin calcium
Change of serum and urin calcium level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Change of serum albumin
Change of serum albumin level before and after iron infusion
Time frame: Baseline and up to 90 days after iron infusion
Complications after iron infusion
Number of patients with complications due to hypophosphatemia after iron infusion (Hospitalization, hypoxia, fracture due to hypophosphatemia)
Time frame: 2015-2022
Predictors
Analysis of possible predictors for the decrease of serum phosphate levels after iron infusion
Time frame: baseline and up to 90 days after iron infusion
Therapeutic management
Descriptive analysis of therapeutic management of hypophosphatemia after iron infusion
Time frame: 2015 to 2022
Plan to share: Undecided
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.